The International Myeloma Foundation Is Creating an Award-Winning Tool for Nurses to Improve Myeloma Patient Outcomes in Underserved Communities Read more about The International Myeloma Foundation Is Creating an Award-Winning Tool for Nurses to Improve Myeloma Patient Outcomes in Underserved Communities Add new comment
‘Dean of Asian Myeloma’ Dr. Kazuyuki Shimizu to Receive First Asian Myeloma Network (AMN) Distinguished Service Award Read more about ‘Dean of Asian Myeloma’ Dr. Kazuyuki Shimizu to Receive First Asian Myeloma Network (AMN) Distinguished Service AwardAdd new comment
European Medicines Agency Recommends Conditional Marketing Authorization of ELREXFIO™ (elranatamab) Read more about European Medicines Agency Recommends Conditional Marketing Authorization of ELREXFIO™ (elranatamab)Add new comment
IMF Chief Medical Officer Dr. Joseph Mikhael Discusses Stem Cell Mobilization in Myeloma with Cure Today Read more about IMF Chief Medical Officer Dr. Joseph Mikhael Discusses Stem Cell Mobilization in Myeloma with Cure TodayAdd new comment
AbbVie Announces Results from Phase III CANOVA Trial of Venetoclax Read more about AbbVie Announces Results from Phase III CANOVA Trial of Venetoclax Add new comment
City of Glendale in Los Angeles County Awarded a Proclamation to the International Myeloma Foundation for Blood Cancer Awareness Month. Read more about City of Glendale in Los Angeles County Awarded a Proclamation to the International Myeloma Foundation for Blood Cancer Awareness Month.Add new comment
The National Comprehensive Cancer Network (NCCN) Presents New Recommendations for Screening and Addressing Health-Related Social Needs (HRSN) in People with Cancer Read more about The National Comprehensive Cancer Network (NCCN) Presents New Recommendations for Screening and Addressing Health-Related Social Needs (HRSN) in People with CancerAdd new comment
FDA Approves APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplant for Multiple Myeloma Patients Read more about FDA Approves APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplant for Multiple Myeloma PatientsAdd new comment
IMF Medical Student Scholars for Health Equity in Myeloma Present Research at the 2023 NMA Annual Convention & Scientific Assembly Read more about IMF Medical Student Scholars for Health Equity in Myeloma Present Research at the 2023 NMA Annual Convention & Scientific Assembly Add new comment
The International Myeloma Foundation Welcomes Global Leader & Patient Advocate Emma Hatcher as Global VP of Patient Engagement & Advocacy Read more about The International Myeloma Foundation Welcomes Global Leader & Patient Advocate Emma Hatcher as Global VP of Patient Engagement & Advocacy Add new comment
